Viewing Study NCT02108860


Ignite Creation Date: 2025-12-25 @ 2:07 AM
Ignite Modification Date: 2026-03-01 @ 10:11 AM
Study NCT ID: NCT02108860
Status: COMPLETED
Last Update Posted: 2024-07-29
First Post: 2014-03-27
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Abatacept for the Treatment of Relapsing, Non-Severe, Granulomatosis With Polyangiitis (Wegener's)
Sponsor: University of South Florida
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Granulomatosis With Polyangiitis (Wegener's) View
None Granulomatosis With Polyangiitis View
None Wegener's Granulomatosis View
None ANCA-Associated Vasculitis View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Granulomatosis with polyangiitis (Wegener's) View
None Granulomatosis with polyangiitis View
None GPA View
None Wegener's granulomatosis View
None Wegener granulomatosis View
None Anti Neutrophil Cytoplasmic Antibody Associated Vasculitis View
None ANCA Associated Vasculitis View
None AAV View
None Vasculitis View
None Systemic vasculitis View
None Systemic inflammatory disease View
None Lung Diseases View
None Respiratory Tract Diseases View
None Vascular Diseases View
None Abatacept View
None CTLA4-Ig View
None Immunosuppressive agent View
None Prednisone View
None Glucocorticoids View
None Glucocorticoid View
None Corticosteroid View
None Corticosteroids View
None Treatment View
None Pharmacologic Actions View
None Therapeutic Uses View
None Anti Inflammatory Agents View